UVA-1 light treatment for hand skin tightness in scleroderma
Part of Skin clinical trials.
This study tests whether UVA-1 light sessions can loosen tight skin and improve hand function in people with scleroderma. If you qualify, you would attend UVA-1 treatments twice a week for the study period.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to understand the study and sign informed consent
- You are age 18 or older
- Your scleroderma affects the skin on both hands about equally
- You can attend UVA-1 sessions twice each week
- Your overall (systemic) scleroderma medicine should not change during the first 100 days
- You should avoid pregnancy during the study period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses ultrasound and nerve tests to understand hand problems in people with scleroderma (systemic sclerosis). It aims to find what causes hand dysfunction.
This study tests whether a special type of massage (connective tissue massage) helps improve hand function and skin tightness in people with scleroderma. It may be a good option if your scleroderma is stable and you can do light exercise.
This trial collects skin samples from people with scleroderma and from healthy volunteers undergoing plastic surgery. Researchers will study the genes in skin cells to better understand the disease.
This trial uses a simple 6-minute pegboard ring test to check how well your hands work. It aims to understand hand function in scleroderma and may help find new ways to track your health.
This study follows adults with systemic scleroderma (also called scleroderma) to better understand the condition over time. You may be included if you meet specific diagnosis and blood-test requirements and can give informed consent.
This study tests whether a person's own fat cells (processed into regenerative cells) can be injected into the hands to improve hand function and reduce skin thickening in systemic sclerosis (scleroderma). It’s designed for people whose hand problems are significant but not too severe.
Hear when a new Scleroderma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.